Journal of Commercial Biotechnology — October 2008

The July 2008 issue of the Journal of Commercial Biotechnology is now available. The links below will take you to the abstract for each paper:

Volume 14, Issue 4


Continuing education in biotechnology PDF
Yali Friedman


Can compliance help marketing and business development? PDF
John Avellanet
Money for nothing? Risks in biopharmaceutical companies from the perspective of public financiers PDF
Laura Heinonen, Birgitta Sandberg
Got value? Determine it. Demonstrate it. Communicate it. Realise it PDF
Mitch DeKoven, Elisabeth H Hazard, Erica Goldberg, Shibani Pokras
Value-driven project and portfolio management in the pharmaceutical industry: Drug discovery versus drug development – Commonalities and differences in portfolio management practice PDF
Kerstin M Bode-Greuel, Klaus J Nickisch

From the Classroom

Open content textbooks: Educating the next generation of bioentrepreneurs in developing economies PDF
Arlen D Meyers, Donald J McCubbrey, Richard T Watson

Legal and Regulatory Updates

Legal and regulatory update PDF
Gerry Kamstra, John Wilkinson

Book Reviews

Book Review: The Regulatory Challenge of Biotechnology PDF
John Avellanet
Book Review: Intellectual Property and Biotechnology: Biological Inventions PDF
Stefan M Miller
Book Review: Commercializing Successful Biomedical Technologies PDF
Arlen D Meyers
Book Review: Enterprise for Life Scientists: Developing Innovation and Entrepreneurship in the Biosciences PDF
Arlen D Meyers
Best Practices in Biotechnology Business Development PDF
Hans-Erik Hamid Lydecker
Genetic Glass Ceilings: Transgenics for Crop Biodiversity PDF
Drew L Kershen
Biotechnology and the Law PDF
Edward L Korwek
Welcome to Biotech Nation PDF
James Rogers

Leave a Reply